Co Enzyme Q10 STUDIES

Highlights Meta-analysis of 6 robust, placebo-controlled trials (8 treatment arms) Statin drugs significantly reduce the blood level of CoQ10 (WMD -0.44 mmol/L) CoQ10 depletion profiles are similar for all four...

Highlights Randomized, double-blind, placebo-controlled trial with 101 patients with dyslipidemia Supplementation consists of CoQ10 (120 mg/day for 24 weeks) Blood pressure and antioxidant status improve after 12 weeks; lipid and glycemic profile, after 24...

Highlights Meta-analysis of 5 randomized, controlled clinical trials involving 194 patients Subjects include patients with and without established cardiovascular disease CoQ10 dosages range from 150 to 300 mg/day; study durations from...

Highlights Meta-analysis of 7 randomized, controlled clinical trials Participants include people with CVD, diabetes and other diseases CoQ10 dosage range 60-300 mg/day, study duration 8 to 12 weeks CoQ10 reduces plasma levels...

Highlights Data extracted from 7 systematic reviews, describing 71 RCTs Interventions compared CoQ10 vs. placebo All systematic reviews in patients with heart failure included Findings suggest CoQ10 may offer clinical...